• Otsuka Pharmaceutical to Acquire Neurovance americanpharmaceuticalreview
    March 06, 2017
    Otsuka Pharmaceutical Co. announced an agreement with Neurovance, Inc. under which OPC has agreed to acquire Neurovance, a privately held, venture-funded, clinical stage pharmaceutical company focused on attention-deficit hyperactivity disorder (ADH
PharmaSources Customer Service